Market 101 – Market Structure The OTCQX, OTCQB and OTC

New Post Public Reply Private Reply Replies (0) Message Board
equijohn

Market 101 – Market Structure

The OTCQX, OTCQB and OTC Pink marketplaces represent U.S. and global public companies that are traded in the U.S. off the exchanges. Investors in the OTCQX, OTCQB and OTC Pink marketplaces can buy and sell securities in a manner almost identical to that of trading NYSE or NASDAQ securities, through the broker of their choice (institutional, online, retail).

There are a few key differences between trading our securities and trading exchange-listed securities which is explained here:  Part 2 - Trading . The five major market participants include:

  • Companies
  • Investors
  • Broker-dealers
  • Regulators
  • Inter-dealer Quotation/Trading Systems (e.g., OTC Markets Group’s OTC Link® ATS)

Each of these participants plays a role in providing information to the marketplace, facilitating liquidity, and driving price transparency.

Companies – Companies sell their securities in public marketplaces to raise capital, complete an acquisition or provide liquidity for existing shareholders to exit their investments. Companies may issue and sell shares in the market pursuant to the safe-harbor guidelines under  SEC Rule 144 and 144A .

Companies that qualify and are current in their financial disclosure may choose to apply to OTC Markets Group’s best marketplace, OTCQX. These companies have the highest average market cap and most liquidity of all the marketplaces. Small and developing companies may report to a U.S. regulator and trade on the OTCQB marketplace, although there are no minimum financial standards. All other companies trade on OTC Pink, which is the default marketplace for broker-dealers who want to trade a security. There is a wide spectrum of securities that provide variable reporting on this marketplace.

Investors – Investors that trade in our marketplaces vary in their knowledge and experience and range from large institutional money managers to high-net worth individuals and other retail investors. OTC Markets Group facilitates information transparency in the market by aggregating and disseminating real-time broker-dealer prices and sizes and by operating the electronic trading platform on which companies trade. OTC Markets Group also provides Investor Relations services to all companies so that they can make their financial and other corporate disclosure readily and widely available to investors.

All investors must execute their transactions (buy and sell orders) in OTCQX, OTCQB and OTC Pink securities through a FINRA-registered broker-dealer. More information on trading is available in  Part 2 – Trading .

Broker-Dealers – FINRA registered broker-dealers may participate in the market by executing client orders and principal orders. Broker-dealers earn revenues from commissions charged on orders, the bid (buy) and ask (sell) spread (the difference between what an investor is willing to buy and sell for a security), and principal trading (investing the firm’s capital in an investment/trading strategy).

Broker-dealers often receive buy and sell orders that ‘match’ – meaning, one client is willing to sell a security for the same price that another client is willing to buy the same security. In this situation, broker-dealers will execute the trade “internally”. Internal execution is preferable for broker-dealers because they receive commissions on both the buy and sell-side of the trade. In executing client orders, broker-dealers may also buy or sell for their own (principal) account, at their own risk. If, however, there is no match for a trade or if a broker-dealer does not wish to trade for his/her own account, then the broker-dealer must find another broker-dealer willing to trade that particular security.

Irrespective of a trade decision regarding a customer order, all broker-dealers must comply with  FINRA Rule 5310 on Best Execution and Interpositioning . ‘Best Execution’ and other customer protection rules are discussed in more detail in  Part 3 - Regulation .

There is no central ‘exchange’ for securities that trade in the OTCQX, OTCQB and OTC Pink marketplaces; therefore, broker-dealers must communicate and trade directly with other broker-dealers. In order to notify other broker-dealers that they are willing to trade a security at a particular price, broker-dealers post their ‘quotes’ on an Inter-dealer Quotation system, such as OTC Link® ATS. The aggregation and ranking of these quotes defines the ‘market’ for a security. The highest ‘bid’ (purchase price) and lowest ‘ask or offer’ (sale price) becomes the ‘inside market’ or NBBO – the National Best Bid and Offer.

If a broker-dealer decides to trade a security, he/she can communicate with other broker-dealer(s), using OTC Link® ATS – OTC Markets Group’s electronic messaging and trade negotiation system – or they may contact the broker-dealer through other means of communication and negotiate the trade.

Regulators – The  Financial Industry Regulatory Authority (FINRA) and the  U.S. Securities and Exchange Commission (SEC) regulate OTC Link® ATS, a trading platform operated by OTC Link LLC, a wholly owned subsidiary of OTC Markets Group. Companies with SEC-registered securities are regulated by the SEC. Similarly, broker-dealers who trade securities using OTC Link® ATS are FINRA members and SEC registered, and may also be subject to various state securities regulations.

Complaints regarding companies should be directed to the  SEC , while complaints regarding broker-dealers or other investment professionals should be directed to  FINRA . More information about specific OTC regulations is covered in  Part 3 – Regulation .

Inter-dealer Quotation/Trading Systems – Inter-dealer Quotation/Trading Systems allow broker-dealers to post and disseminate their ‘quotes’ (prices) to the marketplace and, in the case of OTC Link® ATS, negotiate trades at agreed-upon prices. OTC Link® ATS is the only electronic quotation and trading system in this space. FINRA’s OTC Bulletin Board (OTCBB), on the other hand, is a quotation only system, as it lacks the electronic messaging capabilities of OTC Link® ATS. Furthermore, only companies that are SEC-reporting (or bank/insurance reporting) are eligible for quotation on the FINRA OTCBB. The vast majority of broker-dealers now electronically quote the securities of SEC-reporting companies on the OTCQB marketplace (designed for U.S. companies that report to the SEC or other bank/insurance regulator) through OTC Link® ATS. OTC Link® ATS has effectively replaced FINRA’s OTCBB.

OTC Link® ATS allows broker-dealers to quote any OTC equity security eligible for quoting under  SEC Rule 15c2-11 . Currently, there are over 10,000 securities quoted on the OTC Link® ATS. Broker-dealers access OTC Link® ATS either through OTC Markets Group’s  OTC Dealer or  OTC FIX applications. These applications allow broker-dealers to view all quotes for OTCQX, OTCQB and OTC Pink securities and, if desired, trade those securities through OTC Link® ATS.

OTC Markets Group distributes market data to broker-dealers, investment professionals, market data re-distributors, and financial websites, in addition to providing data through  www.otcmarkets.com .

The real-time dissemination of quote information along with the availability of company financials and news provides price transparency, which allows investors to analyze, value and trade a security. This continuous flow of information between participants defines efficient securities markets.

EJstocks.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Radiofrequency Microneedling: A Fresh Skin Solution?

Updated Category News Views 128

Vet the Process Before Diving In Everyone wants to turn back the clock on their skin, but it's crucial to know what you're getting into. This ain't a quick splash of water on the face; it's radiofrequency microneedling we're talking about. And honey, it’s no fairy tale—it’s science, plain and simple. Drilling Down on Microneedling This procedure, preached by Dr....

Continue Reading
Purina's Docuseries Wins Big at Daytime Emmys

Updated Category News Views 89

Unleashing a Winning Streak Forget stock price fluctuations—Purina Films has struck gold. In a world where brand stories often fall flat or feel contrived, Purina's 'A Different Breed' docuseries just bagged three Daytime Emmy® Awards. It's not every day you see corporate storytelling make a splash like this, but when you blend pets and riveting narratives, magic...

Continue Reading
Flash Tech Sparks New Era in Gas Sensing

Updated Category News Views 38

Revolutionary 10-Millisecond Flash Technique Out of South Korea comes a scientific shake-up that's got eyes on a tiny flash of light poised to change gas sensing technology as we know it. Yep, at Hanyang University ERICA, the boffins have figured out how a quick-fire 10-millisecond zap can turn up the sensitivity dial on gas sensors, especially for the pesky nitrogen...

Continue Reading
KickHouse Partners with Sam Alvey for Glove Line Launch

Updated Category News Views 40

KickHouse Pounces with New Fighter Partnership Looks like KickHouse isn't playing games, folks. They've teamed up with fighter Sam Alvey to launch a new boxing glove line. You got your Warbird, your Desert Ghost, and your Night Ops gloves—names straight out of a war zone. These 16-ounce hammers are out now, and they kickstart a broader gear lineup custom-built for Alvey...

Continue Reading
BioArctic's Moves: Lecanemab Data and Leadership Insights

Updated Category News Views 79

BioArctic's Power Play: A Two-Pronged Update Ever feel like biotechnology is just a series of chess moves? BioArctic's recent maneuvers in the life sciences game certainly hint at that. First, they've got data brewing on lecanemab—this ain't small beans, folks, not with Alzheimer's disease in the crosshairs. Then there's their Nomination Committee. It’s like shaking...

Continue Reading
Ping Identity Tops 2026 Gartner Magic Quadrant: CIAM

Updated Category News Views 20

Turning Heads in the Cybersecurity Space When it comes to digital security, Ping Identity has snagged a top spot in Gartner's 2026 Magic Quadrant for Customer Identity and Access Management (CIAM). Some might gloss over these annual reports like yesterday's news, but Ping isn't just playing around here. They've been tapped as a Leader again, and this accolade highlights...

Continue Reading
Glance's Guide Bridges AI and Human Service Gaps

Updated Category News Views 117

Untangling the AI to Human Transition Ever found yourself stuck in a never-ending loop with AI, screaming for a human voice? You're not alone. According to Glance's 2026 Customer Experience Trends Report, a staggering 76% of consumers are pulling their hair out while repeating themselves when switching service channels. The rub? Only 7% claim they rarely experience this...

Continue Reading
Holiday Shoppers Eye Payment Options Amid Tight Budgets

Updated Category News Views 67

Shoppers Feel the Squeeze As Holidays Approach Hope you brought your umbrella because the holiday season is going to be awash with financial strain and stress for many consumers. According to the latest ETA-TSG Consumer Holiday Spending Study, 44% of consumers are more financially stressed this year compared to last, and the numbers aren't getting any rosier from there....

Continue Reading
Winter Travel Booms: Top Destinations Unveiled for 2026

Updated Category News Views 121

Winter Travel Surge: Rising Demand for Top Destinations Every year as the temperature drops, the excitement for winter travel heats up, and this season's no different. Booking patterns confirm that while people are dreaming of holiday magic, they're also gunning for sun when cold's on the horizon. New York City's holiday glitz leads the domestic charge, backed by a power...

Continue Reading
Orbis International to Boost Global Eye Health Efforts

Updated Category News Views 100

Pledge for Vision In a world where a staggering number of folks wrestle with avoidable vision issues, Orbis International is stepping up to the plate with ambitions that feel as bold as they are necessary. Orbis is pouring a significant $32 million into its mission to beef up eye health systems, train a small army of professionals, and apply AI in eye care. Their big bet...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Developments in Titanium Powder Production by PyroGenesis

Updated Category News Views 156

Significant Contract for Titanium Powder Production PyroGenesis Inc., a pioneer in ultra-high temperature processes and a leading technology provider to heavy industry and defense, is making waves in the additive manufacturing sector. The company has announced an initial order for 'fine cut' titanium powder, which has been produced using their advanced NexGen™ plasma...

Continue Reading
Exploring The Impressive Returns of The Hartford Insurance

Updated Category News Views 254

Understanding The Hartford Insurance Group's Growth The Hartford Insurance Group (NYSE: HIG) has displayed impressive market performance over the past five years, outpacing overall market gains significantly. With an annualized return of 26.43%, this company has offered a noteworthy 12.44% lead over the market average. Current market capitalization stands at approximately...

Continue Reading
Exciting New Consumer Product Launches and Trends This Week

Updated Category News Views 520

Highlights of this Week’s Major Consumer Announcements This week brings an exciting selection of consumer and retail news that you won’t want to miss. From the world of fragrances to the latest Halloween trends, here’s a closer look at some captivating announcements that are making waves. Ariana Grande’s Wicked-Inspired Fragrances Ariana Grande has taken things to...

Continue Reading
Occidental Petroleum's Significant Debt Reduction Achievements

Updated Category News Views 274

Occidental Petroleum's Debt Reduction Strategy In a significant stride towards enhancing its financial health, Occidental Petroleum (NYSE: OXY) announced remarkable progress in its debt reduction efforts, achieving a key target of $4.5 billion by the end of 2024. This noteworthy milestone positions the company well as it navigates the complexities of the evolving energy...

Continue Reading
Aptose Unveils Promising New Therapy for AML Patients

Updated Category News Views 218

Aptose Unveils Promising New Therapy for AML Patients In a groundbreaking development, Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) recently announced that the initial patients have been dosed in the TUSCANY Phase 1/2 trial. This innovative trial evaluates the effectiveness of tuspetinib (TUS) in combination with venetoclax (VEN) and azacitidine (AZA). This trio...

Continue Reading